Asset

CSL LIMITED

CSL
equity
AUD $299.02
stockPerformance 3.77 (1.28%)
Updated: 20 Jan, 5:10 am UTC
02 Jan05 Jan08 Jan11 Jan15 Jan17 Jan20 Jan274276278280282284286288290292294296
Description
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.